Veterinary Rapid Test Market Size, Share & Trends Analysis Report By Product (Test Kits, Readers, By Testing Category, Virology, Parasitology, Bacteriology, Clinical Chemistry, Other Categories), By Technology (Immunoassays, PCR), By Animal Type (Companion Animal, Production Animal), By End Use (Veterinary Hospitals and Clinics, Homecare Settings, Other End Use) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Veterinary Rapid Test Market Size

The global veterinary rapid test market size was valued at USD 824.06 million in 2025 and is projected to grow from USD 894.11 million in 2026 to USD 1717.22 million by 2034, registering a CAGR of 8.5% during the forecast period from 2026 to 2034. North America dominated the veterinary rapid test market with a market share of 38.4% in 2025.

Advancements in diagnostic technologies, such as point-of-care testing and molecular diagnostics, primarily drive the veterinary rapid test market growth.

Rapid tests frequently provide outcomes within a short timeframe, ranging from minutes to a few hours. This enables veterinarians and animal owners to promptly make informed choices regarding treatment and control. Timely detection is vital for efficient therapy and halting the transmission of contagious illnesses across animal populations. The prompt delivery of rapid test findings minimizes the duration between sample collection and diagnosis. Implementing prompt interventions, limiting disease transmission, and enhancing overall animal health outcomes are crucial.

The increasing occurrence of zoonotic diseases and the growing investments by governments and welfare associations globally are expected to drive growth. The market is expected to grow due to the significant occurrence of urinary tract infections (UTIs) in dogs, driving the demand for rapid tests.

Segmentation Analysis

By Product

The test kits segment dominated the market in 2023. Advancements in veterinary diagnostics have created precise and efficient diagnostic test kits that utilize advanced technologies such as polymerase chain reaction (PCR), enzyme-linked immunosorbent assay (ELISA), and lateral flow tests. These advancements enhance the efficiency and efficacy of veterinary diagnostics, consequently promoting market expansion.

The reader segment is the fastest growing. Readers are essential in expanding the market since they enable precise and prompt diagnosis of animal diseases. Veterinarians benefit from their ability to promptly analyze test results, allowing them to make well-informed treatment choices. This, in turn, enhances animal health outcomes and drives up the demand for speedy testing solutions in the veterinary industry.

Request Customizationto receive a tailored report.

By Testing Category

The market is segmented into Virology, Parasitology, Bacteriology, Clinical Chemistry, and Other Categories. The virology segment dominated in 2023. Virology involves the identification of viral infections in animals by utilizing techniques such as viral culture, antigen detection assays, serology, virus isolation, and infection-induced antibodies, which aid in the detection of viral nucleic acids. This segment also involves the surveillance of vaccination efficacy. Other tests in this category include agar-gel immunodiffusion, complement fixation, latex agglutination, hemagglutination inhibition, ELISA, neutralization, and indirect immunofluorescence, all of which detect antibodies using various ways. Antigen detection tests include immunofluorescent antibody detection, immunohistochemistry assays, and antigen ELISA tests.

The bacteriology segment is the fastest growing. Bacteriology is crucial in stimulating the expansion of the veterinary rapid test industry by facilitating the creation of tests for bacterial infections. These tests contribute to the prompt and precise identification of infectious diseases in animals, enabling timely treatment and control of the diseases and improving animal health and productivity.

By Technology

The immunoassays segment dominated in 2023. The immunoassays category includes ELISA/EIA, Lateral Flow Assays (LFAs), and Immunochromatographic Assays (ICA). ELISA rapid test kits are frequently employed in veterinary medicine to identify antibodies or antigens linked to contagious illnesses such as parvovirus infection, distemper, brucellosis, and leptospirosis. ELISA kits are offered in many formats, such as LFAs or Lateral Flow Immunoassays (LFIs), which offer quick and easily understandable outcomes.

The PCR segment is the fastest growing. The Polymerase Chain Reaction (PCR) is crucial in driving the growth of the veterinary rapid test industry. The relevance of this technology rests in its capacity to precisely and swiftly identify pathogens, such as viruses and bacteria, in animals. This aids in the prompt identification of diseases. PCR-based assays have exceptional sensitivity and specificity, allowing veterinarians to quickly detect infectious pathogens, aiding immediate treatment and containment of outbreaks.

In addition, PCR technology enables multiplexing, which means it may detect numerous diseases simultaneously in a single test. This feature enhances its usefulness in veterinary diagnostics. The utilization of PCR-based rapid testing greatly helps the expansion and progress of the veterinary diagnostic market.

By Animal Type

The market is segmented into Companion Animals and Production Animals. The companion animals segment dominated in 2023. These factors can be ascribed to the rise in the pet population, increased pet spending, and the growing awareness of the importance of early disease detection and preventive therapy. The market expansion is anticipated to be driven by the rising number of product launches and robust service pipelines of IDEXX, Zoetis, and Heska Corporation (Mars Inc.) during the forecast period. In June 2023, IDEXX introduced the inaugural animal diagnostic test to identify kidney disease in dogs and cats. The tests will be conducted at IDEXX Reference Laboratories in 2023 in the United States and Canada and introduced in Europe in 2024.

The production animals segment is the fastest growing. The presence of production animals plays a crucial role in driving the growth of the market, as it requires effective disease management. Rapid diagnostic tests facilitate expedited identification of contagious illnesses, guaranteeing timely intervention and averting epidemics that have the potential to decimate cattle herds. Rapid testing is essential in veterinary medicine because it increases production, minimizes economic losses, and emphasizes its indispensability.

By End-User

The market is segmented into Veterinary Hospitals and Clinics, Homecare Settings, and Other End Use. The veterinary hospitals and clinics segment dominated in 2023 due to the growing need for diagnostics and readily available rapid diagnostic tools in hospitals. This sector covers the revenue of veterinary hospitals and clinics directly selling diagnostic test kits to pet owners and livestock farmers. Additionally, veterinary hospitals are responsible for teaching pet owners about the significance of diagnostics in preserving their dogs' well-being. By spreading awareness, they motivate many pet owners to pursue diagnostic test kits when necessary.

The homecare setting segment is the fastest growing. The homecare setting is crucial in promoting and expanding the market for veterinary rapid test by enabling convenient and immediate testing for pet owners. This phenomenon facilitates the early identification and management of diseases, hence improving the well-being of animals. Moreover, it enhances market reach, appealing to a broader range of pet owners searching for effective healthcare options.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America: Dominant Region with 8.2% of the Market Share

North America is the most significant global market shareholder and is estimated to grow at a CAGR of 8.2% over the forecast period. The widespread use of diagnostic tests in the U.S. can be linked to the country's dominant position in the global market, driven by the considerable coverage provided by pet insurance. Pet owners are responsible for ensuring that their pets receive regular medical examinations, often recommended by insurance policies covering a range of diagnostic testing. Canada's need for timely and accurate diagnosis has risen as the number of reportable diseases in livestock, such as avian influenza, bovine tuberculosis, and chronic wasting disease, has increased. The North American market for veterinary diagnostic kits is projected to grow at a favorable rate, primarily due to the demand for early disease detection, especially in the face of rising disease prevalence.

Additionally, the growing utilization of diagnostic testing in the U.S. market can be attributed to its inclusion in pet insurance coverage. In the United States, pet health insurance usually includes coverage for diagnostic procedures such as X-rays, MRI scans, and blood tests. Forbes' data from January 3, 2024, provided information on the mean expense of pet insurance in the United States and the extent of its coverage. The pet insurance offers an annual coverage of USD 5,000, with a deductible of USD 250 and a reimbursement level of 80%. On average, the monthly cost for dog insurance is USD 44, while for cat insurance, it is USD 30.

Unlock Regional Insightsto access country-level data, & regional trends.

Europe: Fastest Growing Region with the Highest Cagr

Europe is anticipated to exhibit a CAGR of 8.9% over the forecast period. Recent advancements in diagnostic technologies, including point-of-care testing and molecular diagnostics, have enhanced the use of veterinary diagnostics. These technologies contribute to the overall demand for veterinary diagnostics by offering precise and efficient diagnostic tests. Pet insurance is essential due to various circumstances, including the rising prevalence of zoonotic diseases in animals and people and the exorbitant expenses associated with treatment. The German market is expected to see a consistently optimistic view due to the high incidence of Urinary Tract Infections (UTIs) in companion animals.

Furthermore, bacterial urinary tract infection (UTI) is a frequently diagnosed condition in companion animals and is the primary reason for prescribing antibiotics. Based on data from a study published in the Antibiotics Journal in 2022, it was determined that uropathogenic bacteria were present in 38.5% of cat samples and 43.9% of dog samples in Germany. In addition, Escherichia coli accounted for 48.4% of the pathogens found, while Coagulase-positive Staphylococci (CoPS) and Enterococcus spp. They made up 11.5% and 11.9% respectively.

The Asia-Pacific market is projected to experience a high CAGR over the forecast period. The Asia-Pacific market, encompassing Thailand, South Korea, Australia, India, China, and Japan, indicates expansion. The market in Thailand is primarily driven by the acceptance of pets and the implementation of breeding techniques in livestock production. The demand for Veterinary Rapid Tests in South Korea is motivated by the significant focus on broiler farms, particularly while combating viral diseases. The prosperous cattle industry in Australia is shown in the widespread implementation of bovine artificial insemination techniques, which have the potential to stimulate market expansion.

List of Key and Emerging Players in Veterinary Rapid Test Market